{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:42:35Z","timestamp":1788824555035,"version":"build-2803163510"},"reference-count":136,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2020,1,2]]},"DOI":"10.1080\/17425255.2020.1702022","type":"journal-article","created":{"date-parts":[[2019,12,7]],"date-time":"2019-12-07T06:27:50Z","timestamp":1575700070000},"page":"45-57","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":40,"title":["Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6996-894X","authenticated-orcid":false,"given":"Rianne A.","family":"Weersink","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Unit of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands"},{"name":"Department of Clinical Decision Support, Health Base Foundation, Houten, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Hayward","sequence":"additional","affiliation":[{"name":"Centre for Liver Disease Research, Translational Research Institute, Faculty of Medicine, The University of Queensland, Brisbane, Australia"},{"name":"Pharmacy Department, Princess Alexandra Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Taxis","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Unit of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P.H.","family":"Drenth","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander D.","family":"Borgsteede","sequence":"additional","affiliation":[{"name":"Department of Clinical Decision Support, Health Base Foundation, Houten, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.05.032"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0145-y"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.09.014"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.005"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60121-5"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1504367"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1021905"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1105-5"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1502-z"},{"key":"CIT0010","first-page":"103","volume-title":"Drugs and the liver: a guide to drug handling in liver dysfunction","author":"Johnson TN","year":"2008"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0553-z"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199529050-00005"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528060-00005"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1007\/BF01960740"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80355-8"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13615"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314966"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.952628"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1007\/BF00278589"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.134"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005280199"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0238-6"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12182"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.09.007"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.05.029"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12963"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.015"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800600817"},{"key":"CIT0029","unstructured":"European Medicines Agency. Guideline on the evaluation of the pharmacokinetics of medicinal products in patients with impaired hepatic function. London. 2005. [cited 2019 Aug 9]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-evaluation-pharmacokinetics-medicinal-products-patients-impaired-hepatic-function_en.pdf"},{"key":"CIT0030","unstructured":"Food and Drug Administration. Guidance for industry: pharmacokinetics in patients with impaired hepatic function: study design, data analysis, and impact on dosing and labeling. Rockville. 2003. [cited 2019 Aug 9]. Available from: https:\/\/www.fda.gov\/media\/71311\/download"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060287"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199324020-00006"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.29306"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1629-y"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1159\/000342906"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0098-2997(99)00005-9"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.118.080523"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1136\/gut.19.12.1110"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12802"},{"key":"CIT0040","unstructured":"Weersink RA, Borgsteede SD, Okel E, et al. Paracetamol use in patients with liver cirrhosis and the risk of hepatotoxicity. Pharm Weekbl. 2016;151(11):22\u201330."},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1097\/01.mjt.0000140216.40700.95"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005280787"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80100-4"},{"key":"CIT0044","author":"Parusov A","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13198"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.132"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80207-8"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.116"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1007\/BF00554663"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1007\/BF00266359"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097885"},{"issue":"6","key":"CIT0052","first-page":"1203","volume":"77","author":"d\u2019Honneur G","year":"1993","journal-title":"Anesth Analg"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199406000-00011"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199911000-00022"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198505000-00010"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.00653.x"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/71.2.227"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/73.5.613"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018901018438"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03700.x"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.87"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04045.x"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03505.x"},{"key":"CIT0064","first-page":"135","volume-title":"Drugs and the liver: a guide to drug handling in liver dysfunction","author":"Croxen F","year":"2008"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20595"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91024-C"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(86)90091-0"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.03.013"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.26295"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987476.ch30"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987476.ch4"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90670-4"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03958.x"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15265"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1177\/2050640617727179"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.046"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.104"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840070403"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1136\/gut.17.12.975"},{"issue":"2","key":"CIT0080","first-page":"322S","volume":"16","author":"Jochemsen R","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023271908568"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840110524"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.116"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.99"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104140"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90956-6"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(86)90558-1"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1600561"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v8.i6.307"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.02.031"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90401-8"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90281-G"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.80"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.4653"},{"key":"CIT0095","first-page":"39","volume":"8","author":"Mitchell O","year":"2016","journal-title":"Hepat Med"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.027"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.06.003"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280535"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.05.011"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-006-9336-5"},{"key":"CIT0101","unstructured":"Aspen Pharma Trading Limited. Summary of product characteristics imuran 25 mg: medicines evaluation board; [updated 2018 December 4; cited 2019 May 28]. Available from: https:\/\/www.geneesmiddeleninformatiebank.nl\/smpc\/h05565_smpc.pdf"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199513050-00004"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90030-O"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)62144-2"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00029-0"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03822.x"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.03.006"},{"key":"CIT0108","unstructured":"Food and Drug Administration. FDA warns about serious liver injury with ocaliva (obeticholic acid) for rare chronic liver disease. 2017. [cited 2019 Sep 2]. Available from: https:\/\/www.fda.gov\/media\/107517\/download"},{"key":"CIT0109","unstructured":"Food and Drug Administration. FDA drug safety communication: FDA warns of serious liver injury risk with hepatitis C treatments viekira pak and technivie. 2015. [cited 2019 Sep 2]. Available from: https:\/\/www.fda.gov\/media\/94262\/download"},{"key":"CIT0110","unstructured":"Health NIo. Drug record - viekira pak: dasabur, ombitasvir, paritraprevir and ritonavir. [updated 2018 Jan 10]. Available from: https:\/\/livertox.nih.gov\/ViekiraPak.htm"},{"key":"CIT0111","unstructured":"Intercept statement regarding ocaliva\u00ae (obeticholic acid) safety and dosing in Primary Biliary Cholangitis (PBC) patients [Internet]. New York: Globe Newswire; 2017; Sept. 25, [4]. Available from: http:\/\/ir.interceptpharma.com\/static-files\/8013669f-4f8c-4543-90eb-8b479682a1e8"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2001.39425"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.128"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.12.007"},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932070-00003"},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12324"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937050-00004"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.902444"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012991"},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0635-x"},{"key":"CIT0121","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199529030-00002"},{"key":"CIT0122","unstructured":"Meda Pharmaceuticals Inc. FDA label edluar - zolpidem tartrate tablet 2013. [cited 2019 Sep 2]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021997s005lbl.pdf"},{"key":"CIT0123","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000894"},{"key":"CIT0124","doi-asserted-by":"publisher","DOI":"10.1177\/875512259901500407"},{"key":"CIT0125","doi-asserted-by":"publisher","DOI":"10.1590\/S1807-59322008000400028"},{"key":"CIT0126","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb02159.x"},{"issue":"1","key":"CIT0127","first-page":"7","volume":"10","author":"Gaillot J","year":"1987","journal-title":"Sleep"},{"key":"CIT0128","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1334"},{"key":"CIT0129","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.13083"},{"key":"CIT0130","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4391-z"},{"key":"CIT0131","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13892"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1177\/2050640616678151"},{"key":"CIT0133","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2729"},{"key":"CIT0134","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01031"},{"key":"CIT0135","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.333.7559.143"},{"key":"CIT0136","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90056-U"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2020.1702022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T19:23:54Z","timestamp":1597692234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2020.1702022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":136,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,2]]}},"alternative-id":["10.1080\/17425255.2020.1702022"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2020.1702022","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-09-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}